Hôpital Roger Salengro

Lille, Nord 59037

2 studies enrolling now · 10 studies all time

What they study most

Alzheimer Disease, Chronic Cluster Headache, Cluster Headache, Episodic, Developmental and Epileptic Encephalopathy, Dravet Syndrome, Medication Overuse Headache, Migraine, Multiple Sclerosis, Parkinson Disease

Studies at this site

• A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) — Recruiting now
• A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) — Enrolling by invitation
• A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) — Running, not enrolling
• To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications — Running, not enrolling
• A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache — Completed
• A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease — Completed
• Eptinezumab in Participants With Episodic Cluster Headache — Completed
• A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) — Completed
• A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments — Completed
• Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex — Completed